Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,456 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Recruiting

A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

NCT07255404

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Tsinghua Changgung Hospital Beijing, China
  • Sichuan Cancer Hospital Chengdu, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, China
  • Zhejiang Provincial People's Hospital Hangzhou, China
View all 24 locations
View Trial Details
Recruiting

AOH1996 for the Treatment of Refractory Solid Tumors

NCT05227326

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +39 more
Locations
  • Honor Health Research and Innovation Institute Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Long Beach Elm Long Beach, California, United States
View Trial Details
Recruiting

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

NCT07562152

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +17 more
Locations
  • City of Hope Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

NCT07409272

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • Mercy Cancer Center Fort Smith, Arkansas, United States
  • Crosson Cancer Institute at Providence St. Jude Medical Center in Fullerton Fullerton, California, United States
  • Cedars-Sinai - Cedars-Sinai Medical Center Los Angeles, California, United States
View all 48 locations
View Trial Details
Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

NCT07644559

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • START- Los Angeles Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View all 19 locations
View Trial Details
Recruiting

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

NCT06593431

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Cooper Hospital University Medical Center Camden, New Jersey, United States
  • Cooper Hospital University Medical Center Voorhees Township, New Jersey, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details

Related conditions